×
About 86,310 results

ALLMedicine Malaria Center

Research & Reviews  40,787 results

His-rich materials: Elucidating the role of histidine-rich protein II in inflammation i...
https://doi.org/10.1111/jth.14780
Journal of Thrombosis and Haemostasis : JTH REFERENCES; Fredenburgh JC

Jun 3rd, 2020 - His-rich materials: Elucidating the role of histidine-rich protein II in inflammation in malaria.|2020|Fredenburgh JC,|

von Willebrand factor increases in experimental cerebral malaria but is not essential f...
https://doi.org/10.1111/jth.14932
Journal of Thrombosis and Haemostasis : JTH; Kraisin S, Martinod K et. al.

Jun 2nd, 2020 - Cerebral malaria (CM) is the most severe complication in malaria. Endothelial activation, cytokine release and vascular obstruction are essential hallmarks of CM. Clinical studies have suggested a link between von Willebrand factor (VWF) and malar...

In vitro transcribed MRNA for expression of designer nucleases: advantages as a novel t...
https://doi.org/10.1016/j.addr.2020.05.010
Advanced Drug Delivery Reviews; Ely A, Singh P et. al.

Jun 2nd, 2020 - Chronic infection with the hepatitis B virus (HBV) remains a significant worldwide medical problem. While diseases caused by HIV infection, tuberculosis and malaria are on the decline, new cases of chronic hepatitis B are on the rise. Because ofte...

Routine data for malaria morbidity estimation in Africa: challenges and prospects.
https://doi.org/10.1186/s12916-020-01593-y
BMC Medicine; Alegana VA, Okiro EA et. al.

Jun 2nd, 2020 - The burden of malaria in sub-Saharan Africa remains challenging to measure relying on epidemiological modelling to evaluate the impact of investments and providing an in-depth analysis of progress and trends in malaria response globally. In malari...

Pregnancy outcomes and risk of placental malaria after artemisinin-based and quinine-ba...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7263905
BMC Medicine; Saito M, Mansoor R et. al.

Jun 2nd, 2020 - Malaria in pregnancy, including asymptomatic infection, has a detrimental impact on foetal development. Individual patient data (IPD) meta-analysis was conducted to compare the association between antimalarial treatments and adverse pregnancy outc...

see more →

Guidelines  19 results

DEET | US EPA
https://www.epa.gov/insect-repellents/deet

May 8th, 2019 - Safety Review of DEET (chemical name, N,N-diethyl-meta-toluamide) is the active ingredient in many repellent products. It is widely used to repel biting pests such as mosquitoes and ticks. Every year, an estimated one-third of the U.S. population ...

DPDx - Laboratory Identification of Parasites of Public Health Concern - CDC
https://www.cdc.gov/dpdx/

Apr 17th, 2019 - Welcome to DPDx, a website developed and maintained by CDC’s Division of Parasitic Diseases and Malaria (DPDM). DPDx uses the Internet to strengthen diagnosis of parasitic diseases, both in the United States and abroad. This interactive and rapid ...

CDC: Artesunate Now First-Line Treatment for Severe Malaria in the United States
https://www.cdc.gov/media/releases/2019/s0328-artesunate-first-line-treatment.html

Mar 27th, 2019 - CDC is issuing new guidance to clinicians for the treatment of severe malaria cases in the United States (U.S.). This change in treatment protocol is necessary because the only FDA-approved intravenous (IV) antimalarial drug in the U.S., quinidine...

Guidelines for Malaria Vector Control
https://www.ncbi.nlm.nih.gov/books/NBK538118/?report=classic

Feb 27th, 2019 - The Guidelines for malaria vector control provide a “one-stop shop” for all countries and partners working to implement effective malaria vector control measures. They cover the 2 core malaria vector control interventions – ITNs and IRS – as well ...

Updated CDC Recommendations for Using Artemether-Lumefantrine for the Treatment of Unco...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898222
MMWR. Morbidity and Mortality Weekly Report; Ballard SB, Salinger A et. al.

Apr 12th, 2018 - Malaria infection during pregnancy is associated with an increased risk for maternal and fetal complications. In the United States, treatment options for uncomplicated, chloroquine-resistant Plasmodium falciparum and P. vivax malaria in pregnant w...

see more →

Drugs  233 results see all →

Clinicaltrials.gov  42,875 results

His-rich materials: Elucidating the role of histidine-rich protein II in inflammation i...
https://doi.org/10.1111/jth.14780
Journal of Thrombosis and Haemostasis : JTH REFERENCES; Fredenburgh JC

Jun 3rd, 2020 - His-rich materials: Elucidating the role of histidine-rich protein II in inflammation in malaria.|2020|Fredenburgh JC,|

von Willebrand factor increases in experimental cerebral malaria but is not essential f...
https://doi.org/10.1111/jth.14932
Journal of Thrombosis and Haemostasis : JTH; Kraisin S, Martinod K et. al.

Jun 2nd, 2020 - Cerebral malaria (CM) is the most severe complication in malaria. Endothelial activation, cytokine release and vascular obstruction are essential hallmarks of CM. Clinical studies have suggested a link between von Willebrand factor (VWF) and malar...

In vitro transcribed MRNA for expression of designer nucleases: advantages as a novel t...
https://doi.org/10.1016/j.addr.2020.05.010
Advanced Drug Delivery Reviews; Ely A, Singh P et. al.

Jun 2nd, 2020 - Chronic infection with the hepatitis B virus (HBV) remains a significant worldwide medical problem. While diseases caused by HIV infection, tuberculosis and malaria are on the decline, new cases of chronic hepatitis B are on the rise. Because ofte...

Routine data for malaria morbidity estimation in Africa: challenges and prospects.
https://doi.org/10.1186/s12916-020-01593-y
BMC Medicine; Alegana VA, Okiro EA et. al.

Jun 2nd, 2020 - The burden of malaria in sub-Saharan Africa remains challenging to measure relying on epidemiological modelling to evaluate the impact of investments and providing an in-depth analysis of progress and trends in malaria response globally. In malari...

Pregnancy outcomes and risk of placental malaria after artemisinin-based and quinine-ba...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7263905
BMC Medicine; Saito M, Mansoor R et. al.

Jun 2nd, 2020 - Malaria in pregnancy, including asymptomatic infection, has a detrimental impact on foetal development. Individual patient data (IPD) meta-analysis was conducted to compare the association between antimalarial treatments and adverse pregnancy outc...

see more →

News  2,363 results

EU Regulator Wants More Data on Malaria Drug's Use for COVID-19
https://www.medscape.com/viewarticle/931387

May 31st, 2020 - (Reuters) - Healthcare professionals should closely monitor COVID-19 patients receiving malaria drug hydroxychloroquine for serious side effects, the European health regulator said on Friday, stressing the need for in-depth clinical data on benefi...

US Hospitals Slash Use of Drug Championed by Trump as Coronavirus Treatment
https://www.medscape.com/viewarticle/931393

May 31st, 2020 - NEW YORK (Reuters) - U.S. hospitals said they have pulled way back on the use of hydroxychloroquine, the malaria drug touted by President Donald Trump as a COVID-19 treatment, after several studies suggested it is not effective and may pose signif...

Sanofi Stops Enrolling COVID-19 Patients in Hydroxychloroquine Trials
https://www.medscape.com/viewarticle/931402

May 31st, 2020 - PARIS (Reuters) - Sanofi has temporarily stopped recruiting new COVID-19 patients for two clinical trials on hydroxychloroquine and will no longer supply the anti-malaria drug to treat COVID-19 until concerns about safety are cleared up, it said o...

France, Italy, Belgium Act to Stop Use of Hydroxychloroquine for COVID-19 on Safety Fears
https://www.medscape.com/viewarticle/931182

May 28th, 2020 - By Reuters Staff PARIS (Reuters) - France, Italy and Belgium acted to halt the use of hydroxychloroquine to treat patients suffering from COVID-19, the illness caused by the new coronavirus, amid questions about the safety of the generic anti-mala...

Hydroxychloroquine Combination Risky for Cancer Patients With COVID-19: Study
https://www.medscape.com/viewarticle/931342

May 28th, 2020 - CHICAGO (Reuters) - Cancer patients with COVID-19 who were treated with a drug combination promoted by U.S. President Donald Trump to counter the coronavirus were three times more likely to die within 30 days than those who got either drug alone, ...

see more →

Patient Education  33 results see all →